SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
(NASDAQ: SPRC) Delayed: 5.29 +0.16 (3.12%)
Previous Close $5.13    52 Week High $ 
Open $5.17    52 Week Low $ 
Day High $5.44    P/E N/A 
Day Low $5.15    EPS $ 
Volume 27,683       

(NASDAQ: SPRC) Delayed: 5.29 +0.16 (3.12%)
Previous Close $5.13    52 Week High $ 
Open $5.17    52 Week Low $ 
Day High $5.44    P/E N/A 
Day Low $5.15    EPS $ 
Volume 27,683